Table 1.
Participants |
Implants |
Gender |
Age (yrs) |
Location |
Bone Type (no. of implants) |
||||
---|---|---|---|---|---|---|---|---|---|
HbA1c at 8 wks | n | n | Number female | Mean ± SE | Number mandible | Type 1 | Type 2 | Type 3 | Type 4 |
≤6.0 | 10 | 12 | 7 | 45.7 ± 3.1b | 7 | 4 | 3 | 5 | 0 |
6.1 to 8 | 12 | 18 | 6 | 66.0 ± 2.2 | 12 | 0 | 7 | 10 | 1 |
8.1 to 10 | 5 | 5 | 2 | 54.4 ± 1.7 | 3 | 0 | 2 | 1 | 2 |
≥10.1 | 5 | 7 | 2 | 64.0 ± 5.1 | 5 | 2 | 2 | 2 | 1 |
Total number | 32 | 42 | 17c | 27d | 6 | 14e | 18e | 4 | |
Significancea | p = 0.7094 | p = 0.0001 | p = 0.9277 | p = 0.0610 |
Test of equality of HbA1c groups.
HbA1c ≤ 6.0 significantly (p ≤ 0.05, Scheffé’s multiple-comparison procedure) different from combined 6.1 to 8.0, 8.1 to 10.0, and ≥10.1.
53.1% of participants were female.
64.3% of implants were in the mandible.
76.2% of implants were in types II or III bone.